Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Fukushima Dai-Ichi Plant Chief to Undergo Medical Treatment

Don't Miss Out —
Follow us on:

Nov. 28 (Bloomberg) -- Masao Yoshida, the manager of Japan’s crippled Fukushima atomic plant, was transferred to the hospital after almost nine months directing efforts to contain the worst nuclear disaster in 25 years.

Tokyo Electric Power Co., the operator of the plant, didn’t specify the ailment or the treatment Yoshida will receive in a statement on the station manager on its website today. Tokyo Electric spokesman Masato Yamaguchi declined to comment further.

“I will concentrate on the treatment and do my best to be at work with you again as soon as possible,” Yoshida wrote in a message to workers at the plant, according to a faxed statement from the utility.

Yoshida, 56, has been at the helm of work to contain the catastrophe at the Fukushima Dai-Ichi station, which was wrecked in the March 11 earthquake and ensuing tsunami. Three reactors melted down, leading to the biggest release of radioactive materials since Chernobyl in 1986.

Yoshida told Tokyo Electric President Toshio Nishizawa on Nov. 21 that he needs treatment after taking medical checks earlier this month, Junichi Matsumoto, a general manager at the company, said in Tokyo today.

Yamaguchi declined to say how much radiation Yoshida has been exposed to.

To contact the reporters on this story: Tsuyoshi Inajima in Tokyo at; Yuji Okada in Tokyo at

To contact the editor responsible for this story: Amit Prakash in Singapore at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.